Jiqian Xu
- Infectious Diseases top 0.1%
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 3
- Neurology top 0.2%
-
- Intensive Care Unit Cognitive Disorders 6
- Modeling and Simulation top 1%
-
- Sepsis Diagnosis and Treatment 8
-
- Respiratory Support and Mechanisms 6
-
- Anesthesia and Sedative Agents 5
-
- Immune cells in cancer 4
-
- Anesthesia and Neurotoxicity Research 3
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jiqian Xu
34 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Infectious Diseases 5.2k
- Neurology 2.8k
- Critical Care and Intensive Care Medicine 742
- Modeling and Simulation 306
- Applied Microbiology and Biotechnology 129
Countries citing papers authored by Jiqian Xu
This map shows the geographic impact of Jiqian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiqian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiqian Xu more than expected).
Fields of papers citing papers by Jiqian Xu
This network shows the impact of papers produced by Jiqian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiqian Xu. The network helps show where Jiqian Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiqian Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 16 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 21 | |
| 8 | 2022 | 40 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 21 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 31 | |
| 15 | 2021 | 34 | |
| 16 | Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studybreakdown → | 2020 | 6803 |
| 17 | 2019 | 46 | |
| 18 | 2019 | 18 | |
| 19 | 2019 | 39 | |
| 20 | 2015 | 58 |
About Jiqian Xu
Jiqian Xu is a scholar working on Critical Care and Intensive Care Medicine, Anesthesiology and Pain Medicine and Developmental Neuroscience, having authored 35 papers that have together received 7.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Sepsis Diagnosis and Treatment (8 papers), Respiratory Support and Mechanisms (6 papers), Intensive Care Unit Cognitive Disorders (6 papers), Anesthesia and Sedative Agents (5 papers), Immune cells in cancer (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Anesthesia and Neurotoxicity Research (3 papers). The work is most often cited by research in Infectious Diseases (5.2k citations), Neurology (2.8k citations) and Critical Care and Intensive Care Medicine (742 citations). Jiqian Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include You Shang, Xiaobo Yang, Yaxin Wang, Yu Yuan, Yongran Wu, Shangwen Pan, Huaqing Shu, Xiaojing Zou, Shiying Yuan and Hong Liu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.